Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers.

Kinsella TJ, Baron ED, Colussi VC, Cooper KD, Hoppel CL, Ingalls ST, Kenney ME, Li X, Oleinick NL, Stevens SR, Remick SC.

Front Oncol. 2011 Jun 30;1:14. doi: 10.3389/fonc.2011.00014. eCollection 2011.

PMID:
22649754
[PubMed]
Free PMC Article
2.

Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.

Morrison SA, Hill SL, Rogers GS, Graham RA.

J Surg Res. 2014 Jun 24. pii: S0022-4804(14)00579-4. doi: 10.1016/j.jss.2014.06.030. [Epub ahead of print]

PMID:
25043529
[PubMed - as supplied by publisher]
3.

Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial.

Baron ED, Malbasa CL, Santo-Domingo D, Fu P, Miller JD, Hanneman KK, Hsia AH, Oleinick NL, Colussi VC, Cooper KD.

Lasers Surg Med. 2010 Dec;42(10):728-35. doi: 10.1002/lsm.20984.

PMID:
21246576
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.

Anderson C, Hrabovsky S, McKinley Y, Tubesing K, Tang HP, Dunbar R, Mukhtar H, Elmets CA.

Photochem Photobiol. 1997 May;65(5):895-901.

PMID:
9155263
[PubMed - indexed for MEDLINE]
5.

Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.

Colussi VC, Feyes DK, Mulvihill JW, Li YS, Kenney ME, Elmets CA, Oleinick NL, Mukhtar H.

Photochem Photobiol. 1999 Feb;69(2):236-41.

PMID:
10048316
[PubMed - indexed for MEDLINE]
6.

Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.

Chan AL, Juarez M, Allen R, Volz W, Albertson T.

Photodermatol Photoimmunol Photomed. 2005 Apr;21(2):72-8.

PMID:
15752124
[PubMed - indexed for MEDLINE]
7.

Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.

Miller JD, Baron ED, Scull H, Hsia A, Berlin JC, McCormick T, Colussi V, Kenney ME, Cooper KD, Oleinick NL.

Toxicol Appl Pharmacol. 2007 Nov 1;224(3):290-9. Epub 2007 Feb 15. Review.

PMID:
17397888
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The relationship of phthalocyanine 4 (pc 4) concentrations measured noninvasively to outcome of pc 4 photodynamic therapy in mice.

Bai L, Guo J, Bontempo FA 3rd, Eiseman JL.

Photochem Photobiol. 2009 Jul-Aug;85(4):1011-9. doi: 10.1111/j.1751-1097.2009.00542.x. Epub 2009 Mar 20.

PMID:
19320848
[PubMed - indexed for MEDLINE]
9.

Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.

Whitacre CM, Feyes DK, Satoh T, Grossmann J, Mulvihill JW, Mukhtar H, Oleinick NL.

Clin Cancer Res. 2000 May;6(5):2021-7.

PMID:
10815928
[PubMed - indexed for MEDLINE]
Free Article
10.

Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer.

Yano T, Muto M, Yoshimura K, Niimi M, Ezoe Y, Yoda Y, Yamamoto Y, Nishisaki H, Higashino K, Iishi H.

Radiat Oncol. 2012 Jul 23;7:113. doi: 10.1186/1748-717X-7-113.

PMID:
22824179
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin.

Agarwal R, Korman NJ, Mohan RR, Feyes DK, Jawed S, Zaim MT, Mukhtar H.

Photochem Photobiol. 1996 Apr;63(4):547-52.

PMID:
8934768
[PubMed - indexed for MEDLINE]
12.

Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome.

Lam M, Lee Y, Deng M, Hsia AH, Morrissey KA, Yan C, Azzizudin K, Oleinick NL, McCormick TS, Cooper KD, Baron ED.

Adv Hematol. 2010;2010:896161. doi: 10.1155/2010/896161. Epub 2010 Dec 12.

PMID:
21197103
[PubMed]
Free PMC Article
13.

A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.

Bhargava P, Marshall JL, Dahut W, Rizvi N, Trocky N, Williams JI, Hait H, Song S, Holroyd KJ, Hawkins MJ.

Clin Cancer Res. 2001 Dec;7(12):3912-9.

PMID:
11751482
[PubMed - indexed for MEDLINE]
Free Article
14.

Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.

Verigos K, Stripp DC, Mick R, Zhu TC, Whittington R, Smith D, Dimofte A, Finlay J, Busch TM, Tochner ZA, Malkowicz S, Glatstein E, Hahn SM.

J Environ Pathol Toxicol Oncol. 2006;25(1-2):373-87.

PMID:
16566729
[PubMed - indexed for MEDLINE]
15.

Irradiation-induced enhancement of Pc 4 fluorescence and changes in light scattering are potential dosimeters for Pc 4-PDT.

Wang KK, Wilson JD, Kenney ME, Mitra S, Foster TH.

Photochem Photobiol. 2007 Sep-Oct;83(5):1056-62.

PMID:
17880500
[PubMed - indexed for MEDLINE]
16.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
[PubMed - indexed for MEDLINE]
17.

Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.

Lam M, Hsia AH, Liu Y, Guo M, Swick AR, Berlin JC, McCormick TS, Kenney ME, Oleinick NL, Cooper KD, Baron ED.

Clin Exp Dermatol. 2011 Aug;36(6):645-51. doi: 10.1111/j.1365-2230.2010.03989.x. Epub 2011 May 30. Review.

PMID:
21623875
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy.

Usuda J, Azizuddin K, Chiu SM, Oleinick NL.

Photochem Photobiol. 2003 Jul;78(1):1-8.

PMID:
12929741
[PubMed - indexed for MEDLINE]
19.

Dissociation of mitochondrial depolarization from cytochrome c release during apoptosis induced by photodynamic therapy.

Chiu SM, Oleinick NL.

Br J Cancer. 2001 Apr 20;84(8):1099-106.

PMID:
11308261
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.

Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Pandey RK, Tsuchida T, Dougherty TJ.

Cancer Res. 2003 Apr 15;63(8):1806-13.

PMID:
12702566
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk